HIGHLIGHTS
- who: Enrico Longato from the Department of Medicine DIMED, University of Padova, Via Giustiniani, Padua, Italy have published the research work: Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis, in the Journal: (JOURNAL) of 11/01/2011
- what: This novel approach of classification by a deep RNN model with attention landscapes reveals the importance of the detailed patient's trajectory of GLM use over time in discriminating subsequent occurrence of a 4P-MACE and highlights some drugs driving the discrimination.
- how: The . . .
  If you want to have access to all the content you need to log in! Thanks :) If you don't have an account, you can create one here.